Autoradiographic Localization of 5-HT_1E and 5-HT_1F Binding Sites in Rat Brain: Effect of Serotonergic Lesioning

References

• Jacobs B. L., Azmitia E. C. Structure and function of the brain serotonin system. Physiol. Rev. 1992; 72: 165–229
   PubMed Web of Science ®Google Scholar
• Siever L. J., Kahn R. S., Lawlor B. A., Trestman R. L., Coccaro E. F. Critical issues in defining the role of serotonin in psychiatric disorders. Pharmacol. Rev. 1991; 43: 509–525
   PubMed Web of Science ®Google Scholar
• Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol. Rev. 1992; 44: 401–458
   PubMed Web of Science ®Google Scholar
• Humphrey P. P.A., Hartig P. R., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 1993; 14: 233–236
   Google Scholar
• Peroutka S. J. 5-Hydroxytryptamine receptors. J. Neurochem. 1993; 60: 408–416
   PubMed Web of Science ®Google Scholar
• Hoyer D., Clarke D. E., Fozard J. R., Hartig P., Martin G. R., Mylecharane E. J., Saxena P. R., Humphrey P. P.A. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine. Pharmacol. Rev. 1994; 46: 157–203, (serotonin)
   PubMed Web of Science ®Google Scholar
• Peroutka S. J. 5-Hydroxytryptamine receptor subtypes. Pharmacol. Toxicol. 1990; 67: 373–383
   PubMedGoogle Scholar
• Barone P., Millet S., Moret C., Prudhomme N., Fillion G. Quantitative autoradiography of 5-HT1Ebinding sites in rodent brains: effect of lesion of serotonergic neurons. Eur. J. Pharmacol. 1993; 249: 221–230
   Google Scholar
• Beer M. S., Stanton J. A., Bevan Y., Chauhan N. S., Middlemiss D. N. An investigation of the 5-HT1Dreceptor binding affinity of 5-hydroxytryptamine, 5-carboxamidotryptamine and sumatriptan in the central nervous system of seven species. Eur. J. Pharmacol. 1992; 213: 193–197
   PubMed Web of Science ®Google Scholar
• Beer M. S., Stanton J. A., Hawkins L. M., Middlemiss D. N. 5-carboxamidotryptamine-insensitive 5-HT1-like receptors are concentrated in guinea pig but not rat, claustrum. Eur. J. Pharmacol. 1993; 236: 167–169
   Google Scholar
• Bruinvels A. T., Palacios J. M., Hoyer D. 5-hydroxytryptamine recognition sites in rat brain: Heterogeneity of non-5-hydroxytryptamine1A/1Cbinding sites revealed by quantitative receptor autoradiography. Neurosci. 1993; 53: 465–473
   Google Scholar
• Peroutka S. J. Cortical and striatal variations in drug competition studies with putative 5-HT1D binding sites. Brain Res. 1991; 553: 206–210
   Google Scholar
• Sumner M.J, Humphrey P. P.A. 5-HT1Dbinding sites in porcine brain can be subdivided by GR-43175. Br. J. Pharmacol. 1989; 98: 29–31
   Google Scholar
• Waeber C., Schoeffter P., Palacios J. M., Hoyer D. Molecular pharmacology of 5-HT1Drecognition sites: radioligand binding studies in human, pig and calf brain membranes. Naunyn Schmiedeberg's Arch. Pharmacol. 1988; 337: 595–601
   Google Scholar
• Bruinvels A. T., Landwehrmeyer B., Probst A., Palacios J. M., Hoyer D. A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands. Brain Res. Mol. Brain Res. 1994; 21: 19–29
   PubMedGoogle Scholar
• Leonhardt S., Herrick-Davis K., Titeler M. Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein. J. Neurochem. 1989; 53: 465–471
   PubMed Web of Science ®Google Scholar
• Gudermann T., Levy F. O., Birnbaumer M., Birnbaumer L., Kaumann A. J. S31 serotonin receptor clone encodes a 5-hydroxytryptamine1E-like serotonin receptor. Mol. Pharmacol. 1993; 43: 412–418
   PubMed Web of Science ®Google Scholar
• Levy F. O., Gudermann T., Birnbaumer M., Kaumann A. J., Birnbaumer L. Molecular cloning of a human gene (S31) encoding a novel serotonin receptor mediating inhibition of adenylate cyclase. FEBS Lett. 1992; 296: 201–206
   PubMed Web of Science ®Google Scholar
• McAllister G., Charlesworth A., Snodin C., Beer M. S., Noble A. J., Middlemiss D. N., Iversen L. L., Whiting P. Molecular cloning of a serotonin receptor from human brain (5-HT1E): A fifth 5-HT1-like subtype. Proc. Natl. Acad. Sci. USA 1992; 89: 5517–5521
   PubMed Web of Science ®Google Scholar
• Zgombick J. M., Schechter L. E., Macchi M., Hartig P. R., Branchek T. A., Weinshank R. L. Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1Ereceptor. Mol. Pharmacol. 1992; 42: 180–185
   PubMed Web of Science ®Google Scholar
• Adham N., Hung-Teh K., Schechter L. E., Bard J., Olsen M., Urquhart D., Durkin M., Hartig P. R., Weinshank R. L., Branchek T. A. Cloning of another human serotonin receptor (5-HT1F): A fifth 5-HT1receptor subtype coupled to the inhibition of adenylate cyclase. Proc. Natl. Acad. Sci. USA 1993; 90: 408–412, 1
   PubMed Web of Science ®Google Scholar
• Amlaiky N., Ramboz S., Boschert U., Plassat J.-L., Hen R. Isolation of a mouse “5-HT1E-like” serotonin receptor expressed predominantly in hippocampus. J. Biol. Chem. 1992; 267: 19761–19764
   PubMed Web of Science ®Google Scholar
• Lovenberg T. W., Erlander M. G., Baron B. M., Racke M., Slone A. L., Siegel B. W., Craft C. M., Burns J. E., Danielson P. E., Sutcliffe J. G. Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes. Proc. Natl. Acad. Sci. USA 1993; 90: 2184–2188
   PubMed Web of Science ®Google Scholar
• Adham N., Borden L. A., Schechter L. E., Gustafson E. L., Cochran T. L., Vaysse P. J.-J.;, Weinshank R. L., Branchek T. A. Cell-specific coupling of the cloned human 5-HT1Freceptor to multiple signal transduction pathways. Naunyn Schmiedeberg's Arch. Pharmacol. 1993; 348: 566–575
   Google Scholar
• Briley M., Chopin C., Moret C. Effect of serotonergic lesion on ‘anxious’ behaviour measured in the elevated plus-maze test in the rat. Psychopharmacol. 1990; 101: 187–189
   PubMed Web of Science ®Google Scholar
• Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York 1986
   Google Scholar
• Pazos A., Hoyer D., Palacios J. M. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. Eur. J. Pharmacol. 1984; 106: 539–546
   PubMed Web of Science ®Google Scholar
• Lowther S., De Parmentier F., Crompton M. R., Horton R. W. The distribution of 5-HT1Dand 5-HT1Ebinding sites in human brain. Eur. J. Pharmacol. 1992; 222: 139–142
   Google Scholar
• Gerald C., Adham N., Kao H.-T., Olsen M. A., Laz T. M., Schechter L. E., Bard J. A., Vaysse P. J.-J., Hartig P., Branchek T. A., Weinshank R. L. The 5-HT4receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J. 1995; 14: 2806–2815
   PubMed Web of Science ®Google Scholar
• Matthes H., Boschert U., Amlaiky N., Grailhe R., Plassat J.-L., Muscatelli F., Mattei M.-G., Hen R. Mouse 5-hydroxytryptamine5Aand 5-hydroxytryptamine5Breceptors define a new family of serotonin receptors: cloning, functional expression, and chromosomal localization. Mol. Pharmacol. 1993; 43: 313–319
   PubMed Web of Science ®Google Scholar
• Monsma F. J., Jr., Shen Y., Ward R. P., Harnblin M. W., Sibley D. R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 1993; 43: 320–327
   PubMed Web of Science ®Google Scholar
• Shen Y., Monsma F. J., Metcalf M. A., Jose P. A., Hamblin M. A., Sibley D. R. Molecular cloning and expression of a 5-hydroxytryptamine7serotonin receptor subtype. J. Biol. Chem. 1993; 268: 18200–18204
   PubMed Web of Science ®Google Scholar
• Jacobs B. L., Fornal C. A. 5-HT and motor control: a hypothesis. Trends Neurosci. 1993; 16: 346–352
   PubMed Web of Science ®Google Scholar
• Bruinvels A. T., Landwehrmeyer B., Gustafson E. L., Durkin M. M., Mengod G., Branchek T. A., Hoyer D., Palacios J. M. Localization of 5-HT1B, 5-HT1D alpha, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain. Neuropharmacol. 1994; 33: 367–386
   PubMed Web of Science ®Google Scholar
• Fichette C., Nock B., Renner K. Effect of 5,7-DHT on serotonin 1 and serotonin 2 receptors throughout the rat central nervous system using quantitative autoradiography. Brain Res. 1987; 421: 263–279
   Google Scholar
• Manrique C., Segu L., Héry F., Héry M., Faudon M., François-Bellan A. M. Increase of central 5-HT1Bbinding sites following 5,7-dihydroxytryptamine axotomy in adult rat. Brain Res. 1993; 623: 345–348
   PubMedGoogle Scholar
• Quirion R., Richard J. Differential effects of selective lesions of cholinergic and dopaminergic neurons on serotonin-type 1 receptors in rat brain. Synapse 1987; 1: 124–130
   Google Scholar
• Vergé D., Daval G., Marcinkiewicz M., Patey A., El Mestikawy S., Gozlan H., Hamon M. Quantitative autoradiography of multiple 5-HT1receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J. Neurosci. 1986; 6: 3474–3482
   Google Scholar
• Moret C., Briely M. Dihydroergocristine-induced stimulation of the 5-HT autoreceptor in the hypothalamus of the rat. Neuropharmacol. 1986; 25: 169–174
   Google Scholar
• Price G. W., Watson J., Roberts C., Jones B. K. Multiple 5-HT terminal autoreceptors in guinea-pig cerebral cortex demonstrated by in vitro [3H]5-HT release. Br. J. Pharmacol. 1993; 108: 101P
   Google Scholar
• Wilkinson L. O., Middlemiss D. N. Metitepine distinguishes two receptors mediating inhibition of [3H]-5-Hydroxytryptamine release in guinea pig hippocampus. Naunyn Schmiedeberg's Arch. Pharmacol. 1992; 345: 696–699
   Google Scholar
• Goldfarb J. Electrophysiologic studies of serotonin receptor activation: answered and unanswered questions. Neuropsychopharmacol. 1990; 3: 435–446
   Google Scholar
• Nedergaard S., Bolam J. P., Greenfield S. A. Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature 1988; 333: 174–177
   PubMed Web of Science ®Google Scholar